VINP Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Loading...
VINP is not a good buy right now for an impatient buyer. Price momentum is still deteriorating (bearish MACD expansion) and there is no proprietary buy signal to override the weak tape. The better risk/reward setup would be after a clear reclaim of ~12.68 (pivot) or a clean hold-and-bounce off 12.19/11.88 support; at the current 12.51, the chart does not yet show that confirmation.
VINP closed at 12.51 (-2.95%), sitting below the pivot level (12.681), which keeps near-term bias weak. MACD histogram is negative (-0.0478) and negatively expanding, indicating downside momentum is still building rather than stabilizing. RSI(6) at ~32.98 is low (near oversold), which can support a bounce, but it is not a confirmed reversal signal on its own. Moving averages are converging, implying consolidation/indecision rather than an established uptrend. Key levels: Support S1=12.189 then S2=11.884; Resistance R1=13.174 then R2=13.479. A bullish reclaim and hold above ~12.68 followed by a move toward 13.17 would improve the buy case; a breakdown below 12.19 increases odds of a quick drop toward ~11.88.
Strong top-line growth in the latest quarter (2025/Q3 revenue +110.56% YoY).
Net income growth (+17.51% YoY) supports fundamental momentum.
Options market skew is call-favoring (low put/call ratios), suggesting constructive sentiment.
Pattern-based projection shows a positive skew over the next month (+11.66%), despite near-term chop.
Short-term technicals are bearish: price below pivot and MACD momentum worsening.
EPS declined slightly in 2025/Q3 (-2.63% YoY), which can cap enthusiasm despite revenue growth.
No recent news/catalysts to arrest the current down-move; next major event is earnings (2026-02-25), which can keep trading choppy.
Hedge fund and insider trends are neutral (no supportive flow signal).
Latest quarter: 2025/Q3. Revenue rose to 241,313,000 (+110.56% YoY), indicating strong growth. Net income increased to 49,246,000 (+17.51% YoY), but EPS slipped to 0.74 (-2.63% YoY), implying share count/expenses/mix may be diluting per-share growth. Gross margin is shown as 0 (likely missing/placeholder in the snapshot), so margin trend can’t be reliably assessed from the provided data.
No analyst rating or price target change data was provided, so there is no observable recent Wall Street upgrade/downgrade trend to lean on. Pros (based on available fundamentals): strong revenue growth and higher net income. Cons: EPS down slightly and the chart is currently weak, which often makes analysts more cautious until post-earnings clarity.
